The Uromigos

The Uromigos

By The Uromigos
Broadcasting the latest developments in GU cancer
Where to listen
Apple Podcasts Logo
Breaker Logo
Google Podcasts Logo
Pocket Casts Logo
RadioPublic Logo
Spotify Logo
Currently playing episode

Episode 10: COVID-19 and Renal Cancer: A Patient's Perspective

The Uromigos

Go to next audioGo to next audio
Go to prev audioGo to prev audio
1x
Episode 45: The Uromigos World Tour arrives in Japan
Yoshi Tomita explains treatment pathways and research in GU cancer in Japan. Brian explains why he likes Japan so much. 
20:29
July 3, 2020
Episode 44: The Uromigos World Tour in Australia - Talking with Ian Davis about prostate cancer and ANZUP
Ian Davis discusses why ANZUP has been so successful, and the EnzaMet study. An uninvited guest arrives towards the end. 
31:51
July 3, 2020
Episode 43: The Uromigos World Tour in Singapore with Ravi Kanesvaran
Ravi describes treatment pathways and research for Southeast Asia in GU cancer. 
18:20
June 29, 2020
Episode 42: The Uromigos in Argentina
Juan Sade discusses research, treatment pathways in GU cancer, steak and red wine in Argentina. 
12:08
June 28, 2020
Episode 41: The Uromigos World Tour lands in Brazil - Fernando Maluf talks about prostate cancer and recent research in Brazil
The tour lands in sunny Brazil with a trip to a Japanese restaurant and a discussion about research and prostate cancer. 
24:04
June 25, 2020
Episode 40: The Uromigos World Tour moves to France - Bernard Escudier discusses 2nd line therapy in renal cancer and Tivozanib
The Uromigos World Tour moves to Paris. Treatment for tumours that progress after first line immunetherapy is discussed. The role of Tivozanib is a focus for the dialogue. 
20:02
June 22, 2020
Episode 39: The Uromigos World Tour - Renal Cancer and IMDC Risk with Danny Heng in Calgary
Danny discusses Italian food and the past, present and future of the IMDC prognostic score. 
20:17
June 18, 2020
Episode 38: The Uromigos Virtual World Tour - starting in Vancouver with Atezolizumab in NMIBC
Peter Black talks about his recent BCG refractory NMIBC ASCO presentation and its implications for the field. 
20:21
June 16, 2020
Episode 37: Regoratinib (FGFR inhibitor) and Atezolizumab in UC with Jonathan Rosenberg
Everything you wanted to know about FGFR inhibition but were afraid to ask. 
18:11
June 1, 2020
Episode 36: Dr. Tian Zhang discusses three ASCO bladder cancer abstracts with immune therapy/targeted therapy combinations
 Tian Zhang discusses three ASCO bladder cancer abstracts with immune therapy/targeted therapy combinations
20:58
June 1, 2020
Episode 35: Maintenance Avelumab in Bladder Cancer (LBA1)
Dr. Kala Sridhar, Professor Tom Powles and Dr. Brian Rini discuss the data presented at ASCO. 
17:41
May 31, 2020
Episode 34: Savolitinib in Renal Papillary Cancer - A Major Breakthrough?
Dr. Toni Choueiri discusses the results of this study, which appears to show a survival signal, but it is difficult to interpret. 
20:40
May 30, 2020
Episode 33: Adjuvant Atezolizumab in Urothelial Cancer
Joaquim Bellmunt explains a bit about why this trial was not successful and what it means for the field. 
19:59
May 29, 2020
Episode 32: A Phase 2 Study of PSMA PET in Prostate Cancer with Thomas Hope from ASCO 2020
Thomas Hope is quizzed on the results of his study presented at ASCO20.
24:09
May 29, 2020
Episode 31: A Phase 2 Study of Nivolumab with the Addition of Ipilimumab Upon Progression in Renal Cancer
Mike Atkins describes the results of this study which helps shed light on the role of ipilimumab and nivolumab in this disease. 
25:18
May 29, 2020
Episode 30: Update on Axitinib plus Pembrolizumab in Renal Cancer (KEYNOTE 426)
Betsy Plimack discusses the updated data with a minimum of 23 months' follow up. Dr. Brian Rini and Professor Tom Powles asks what it adds. 
20:03
May 29, 2020
Episode 29: PSMA PET at ASCO 2020 with Mike Morris
Mike Morris presents the findings in his prospective study. 
23:47
May 29, 2020
Episode 28: Targeting VHL Syndrome Renal Cancer with a HIF Inhibitor - A Game Changer
Eric Jonasch discusses his ASCO presentation, which shows significant activity of HIF targeting in renal cancer patients with VHL syndrome. 
13:31
May 29, 2020
Episode 27: COVID-19 in > 1000 Cancer Patients with Jeremy Warner (CCC-19)
Jeremy Warner summarises the recent Lancet paper describing the outcome of cancer patients with COVID-19. 
21:44
May 29, 2020
Episode 26: Joaquim Bellmunt and Muscle Invasive Bladder Cancer prior to ASCO 2020
Joaquim Bellmunt talks about management of muscle invasive bladder cancer prior to the Atezolizumab adjuvant data at ASCO20. 
22:23
May 19, 2020
Episode 25: Dr. Tian Zhang discusses first line treatment for renal cancer and the PDIGREE Trial
Dr. Tian Zhang discusses first line treatment for renal cancer and the PDIGREE Trial.
14:47
May 19, 2020
Episode 24: A Study of COVID-19 in Lung Cancer Shows High Mortality
Marina Garassino and Leora Horn discuss their AACR study of COVID-19 in lung cancer.
19:51
April 28, 2020
Episode 23: Atezolizumab and Enzalutamide versus Enzalutamide Prostate Cancer
Chris Sweeney explains why the trial was negative and answers some of the questions.
22:35
April 28, 2020
Episode 22: COVID-19 and Cardiovascular Disease
Kaushik Amancherla and Javid Moslehi discuss the link of COVID-19 and cardiovascular disease. Professor Tom Powles and Dr. Brian Rini struggle to keep up.
18:28
April 22, 2020
Episode 21: Treating cancer patients over the next year in the era of COVID-19
The Uromigos struggle to describe what cancer care looks like in three months’ time during the COVID-19 pandemic.
12:33
April 15, 2020
Episode 20: Treating GU Cancer Patients with acute COVID-19 Infection
The Uromigos can’t agree on how to approach COVID-infected GU cancer patients who need systematic treatment.
13:07
April 15, 2020
Episode 19: Professor Monty Pal discusses the treatment of non-clear cell renal cancer
Professor Monty Pal discusses non-clear cell renal cancer while Dr. Brian Rini gets irritated by background interruptions. 
18:17
April 15, 2020
Episode 18: COVID-19: Addressing Renal Cancer Patients’ Concerns
Dena Battle presents a 500-patient survey on issues around COVID-19. Professor Tom Powles and Dr. Brian Rini attempt to address the issues raised.
24:46
April 6, 2020
Episode 17: Dr. Toni Choueiri discusses cancer trials and meetings during COVID-19
Professor Tom Powles, Dr. Brian Rini and Dr. Toni Choueiri discuss the evolving landscape in Boston, and meetings such as ASCO and ESMO in 2020.
21:33
April 2, 2020
Episode 16: Treatments and Trials for COVID-19
Professor Nick Mark discusses the latest data on drug treatments and trials for COVID-19.
25:31
March 31, 2020
Episode 15: COVID-19 and Bladder Cancer Surgery
The Uromigos discuss the practicalities in surgery for bladder cancer in the era of COVID-19 with Betsy Plimack (Fox Chase Cancer Center, Philadelphia)
14:52
March 28, 2020
Episode 14: A Discussion about Tocilizumab and COVID-19 with Dr. Nick Mark from Seattle
Dr. Brian Rini and Professor Tom Powles discuss the data and ongoing studies with the IL-6 antibody tocilizumab.
15:04
March 24, 2020
Episode 13: COVID-19 and Hydroxychloroquinine Existing Data and Ongoing Trials
Dr. David Boulware discusses existing data and ongoing prophylaxis studies.
18:44
March 23, 2020
Episode 12: COVID-19 in Cancer Patients - The Seattle Experience
A discussion with doctors from the Fred Hutchinson Cancer Center in Seattle about COVID-19.
26:19
March 20, 2020
Episode 11: COVID-19 and Immune Checkpoint Inhibitors for the Treatment of Cancer
Chuck Drake and Doug Johnson discuss possible risk benefits of immune checkpoint inhibitors during the COVID-19 pandemic. 
17:43
March 16, 2020
Episode 10: COVID-19 and Renal Cancer: A Patient's Perspective
Dena Battle (President, KCCure) asks key patient-focused questions about kidney cancer management during the COVID-19 pandemic. 
27:09
March 16, 2020
Episode 9: COVID-19 and Cancer: An International Perspective
Five members of the groups from Europe and North America discuss the current situation for cancer patients. 
21:58
March 16, 2020
Episode 8: COVID-19 and Cancer Patients
Professor Tom Powles and Dr. Brian Rini discuss the virus with an expert, Ronan Breen. 
21:54
March 13, 2020
Episode 7: The First Uromigos Prostate Cancer Podcast
Silke Gillessen and Chris Sweeney discuss how data from recent ESMO and GU ASCO meetings has changed the way they treat prostate cancer. 
25:32
February 27, 2020
Episode 6: Urothelial Cancer Highlights from ASCO GU 2020
In this episode, Professor Tom Powles and Dr. Brian Rini talk to Dr. Kala Sridhar about key developments in urothelial cancer presented at ASCO GU 2020. 
20:08
February 26, 2020
Episode 5: Renal Highlights from ASCO GU 2020
Professor Tom Powles and Dr. Brian Rini broadcast from ASCO GU 2020, San Francisco. 
10:14
February 24, 2020
Episode 4: Treatment Choices in Front Line Advanced Renal Cancer
Dr. Brian Rini and Professor Tom Powles ask David McDermott about how he chooses between ipilimumab/nivolumab or axitinib/pebrolizumab intreatment options
26:39
February 11, 2020
Episode 3: Pembrolizumab in Non-Muscle Invasive Bladder Cancer
Guests Dr. Arjun Balar and Professor Seth Lerner give an overview of the recent FDA approval of pembrolizumab in this indication to Professor Tom Powles and Dr. Brian Rini.
33:02
February 11, 2020
Episode 2: The Current role of IO in Front-line Advanced Urothelial Cancer
Matthew Galski and Petros Grivas engage in a discussion with Professor Tom Powles and Dr. Brian Rini about IMVIGOR130.
30:18
February 11, 2020
Episode 1: Introduction to Uromigos Podcasts
Professor Tom Powles and Dr. Brian Rini discuss the purpose of the podcasts and how to complain if you don’t like them
03:20
February 11, 2020